Literature DB >> 16445579

Increased responsiveness to 5-hydroxytryptamine after antigenic challenge is inhibited by nifedipine and niflumic acid in rat trachea in vitro.

Carlos Tiago Martins Moura1, Fernanda Carvalho Bezerra, Isabelle Maciel de Moraes, Pedro Jorge Caldas Magalhães, Francisco Ruy Capaz.   

Abstract

Antigenic challenge often induces hyperreactivity in asthmatic airway, although the precise mechanism(s) underlying this increased responsiveness is not entirely known. Tracheae obtained from ovalbumin (OVA)-sensitized saline- or OVA-challenged rats were placed in 10 mL bath chambers for isometric recording of 5-hydroxytryptamine (5-HT)-induced contractions. 5-Hydroxytryptamine induced a stronger contraction compared with control in antigen-challenged trachea under normal or Ca2+-free conditions. In tracheae pretreated with the L-type Ca2+ channel blocker nifedipine (10(-6) mol/L) or the Ca2+-activated Cl- channel blocker niflumic acid (10(-4) mol/L), this hyperresponsiveness was not developed in either normal or Ca2+-free medium. The increased contractile response to 5-HT in allergic rat isolated trachea may be related to a greater ionic (Ca2+ and Cl-) channel involvement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16445579     DOI: 10.1111/j.1440-1681.2005.04308.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

1.  Luminal cholinergic signalling in airway lining fluid: a novel mechanism for activating chloride secretion via Ca²⁺-dependent Cl⁻ and K⁺ channels.

Authors:  Monika I Hollenhorst; Katrin S Lips; Miriam Wolff; Jürgen Wess; Stefanie Gerbig; Zoltan Takats; Wolfgang Kummer; Martin Fronius
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.

Authors:  Lioubov I Brueggemann; Jennifer M Haick; Samantha Neuburg; Shawn Tate; Devjit Randhawa; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-17       Impact factor: 5.464

3.  Allergen and ozone exacerbate serotonin-induced increases in airway smooth muscle contraction in a model of childhood asthma.

Authors:  Brian D Moore; Dallas Hyde; Lisa Miller; Emily Wong; Jessica Frelinger; Edward S Schelegle
Journal:  Respiration       Date:  2012-04-13       Impact factor: 3.580

4.  Functional and morphologic dysfunctions in the airways of rats submitted to an experimental model of obesity-exacerbated asthma.

Authors:  Sarah Rebeca Dantas Ferreira; Rayane Fernandes Pessoa; Indyra Alencar Duarte Figueiredo; João Pedro Moura Lima; Thayna Maria Costa Fernandes de Moura; Cleyton Oliveira Bezerra; Alissa Maria de Oliveira Martins; Leila Moreira de Carvalho; Marta Suely Madruga; Hassler Clementino Cavalcante; Jailane de Souza Aquino; José Luiz de Brito Alves; Adriano Francisco Alves; Luiz Henrique César Vasconcelos; Fabiana de Andrade Cavalcante
Journal:  Sci Rep       Date:  2022-06-09       Impact factor: 4.996

5.  Urtica dioica attenuates ovalbumin-induced inflammation and lipid peroxidation of lung tissues in rat asthma model.

Authors:  Hanene Zemmouri; Omar Sekiou; Sonda Ammar; Abdelfattah El Feki; Mohamed Bouaziz; Mahfoud Messarah; Amel Boumendjel
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  Naringenin Improves Ovalbumin-Induced Allergic Asthma in Rats through Antioxidant and Anti-Inflammatory Effects.

Authors:  Seyed Vahid Jasemi; Hosna Khazaei; Sajad Fakhri; Ehsan Mohammadi-Noori; Mohammad Hosein Farzaei
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-04       Impact factor: 2.629

7.  Development and Characterization of an Allergic Asthma Rat Model for Interventional Studies.

Authors:  Marta Périz; Francisco J Pérez-Cano; Maria J Rodríguez-Lagunas; Trinitat Cambras; Santiago Pastor-Soplin; Iván Best; Margarida Castell; Malén Massot-Cladera
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.